The Valley Desk

NCT02710396 · Interventional trial

Genetic Predictors of Benefit to Pembrolizumab

Overall registry status Terminated

Phase 2

Conditions Carcinoma, Non-Small-Cell Lung

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov